Skip to main content
Premium Trial:

Request an Annual Quote

BioNanomatrix Wins $397K NHGRI Grant to Develop Its Genome Sequencer

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has awarded BioNanomatrix a $397,750 research grant to develop its nanoscale whole genome imaging platform, the company said today.
 
BioNanomatrix is developing a system that allows nanoscale single molecule identification and analysis of the entire genome. The system’s ability to deliver single molecule sensitivity in a highly parallel format with minimal processing will reduce cost and time spent on extensive data and integrative analyses, the company said.
 
The NHGRI awarded the two-year Small Business Investment Research grant under the NIH BioEngineering Nanotechnology Initiative.
 
This is BioNanomatrix’s second NIH grant this year. The company received a National Cancer Institute grant in May to develop a cancer diagnostic prototype.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.